Which is better in patients with curatively resected extrahepatic biliary tract cancer? Adjuvant concurrent chemoradiation (CCRT) alone versus CCRT followed by maintenance chemotherapy

被引：0
|
作者：
Lim, K. [1 ]
Oh, D. [1 ]
Chie, E. [1 ]
Jang, J. [1 ]
Im, S. [1 ]
Kim, T. [1 ]
Kim, S. [1 ]
Ha, S. [1 ]
Bang, Y. [1 ]
机构：
[1] Seoul Natl Univ Hosp, Seoul 110744, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15659
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15659
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Comparative Effectiveness of Neoadjuvant Chemoradiation Therapy Versus Chemotherapy Alone Followed by Surgery for Patients With Stage III Non-Small Cell Lung Cancer (NSCLC)
    Sher, D. J.
    Fidler, M.
    Liptay, M. J.
    Koshy, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S55 - S55
  • [42] Comparative Effectiveness of Neoadjuvant Chemoradiation Therapy Versus Chemotherapy Alone Followed by Surgery for Patients With Stage III Non-small Cell Lung Cancer (NSCLC)
    Sher, D. J.
    Fidler, M.
    Liptay, M. J.
    Koshy, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S145 - S146
  • [43] Efficacy and final safety analysis of pre- and co-administration of nivolumab (Nivo) with concurrent chemoradiation (CCRT) followed by Nivo maintenance therapy in patients (pts) with locally advanced cervical carcinoma (LACvCa): Results from the phase I trial, GOTIC018
    Nakamura, Kazuto
    Yabuno, Akira
    Satoh, Toyomi
    Fujiwara, Hiroyuki
    Kurosaki, Akira
    Yamashita, Soichi
    Misumi, Toshihiro
    Noda, Shin-ei
    Hasegawa, Kosei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [44] A randomized phase III study of hepatic arterial infusion chemotherapy with 5-fluorouracil and subsequent systemic chemotherapy versus systemic chemotherapy alone for colorectal cancer patients with curatively resected liver metastases (Japanese Foundation for Multidisciplinary Treatment of Cancer 32)
    Kusano, Mitsuo
    Aoyama, Toru
    Okabayashi, Koji
    Hirata, Koichi
    Tsuji, Yasushige
    Nakamori, Shoji
    Asahara, Toshimasa
    Ohashi, Yasuo
    Yoshikawa, Takaki
    Sakamoto, Junichi
    Oba, Koji
    Saji, Shigetoyo
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 : S761 - S766
  • [45] Neoadjuvant versus adjuvant chemotherapy with taxanes and anthracycline-based regimen: Which leads to better outcome in patients with different subtype breast cancer?
    Yang, Houpu
    Wang, Shu
    Zhou, Lixin
    Guo, Jiajia
    Cao, Yingming
    Zhou, Bo
    Cheng, Lin
    Xie, Fei
    Liu, Hongjun
    Tong, Fuzhong
    Liu, Miao
    Liu, Peng
    Wang, Siyuan
    Yang, Deqi
    Zhang, Jiaqing
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [46] Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer stage III and IV nasopharyngeal cancer of the endemic variety
    Wee, J
    Tan, EH
    Tai, BC
    Wong, HB
    Leong, SS
    Tan, T
    Chua, ET
    Yang, E
    Lee, KM
    Fong, KW
    Tan, HSK
    Lee, KS
    Loong, S
    Sethi, V
    Chua, EJ
    Machin, D
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) : 6730 - 6738
  • [47] A randomized phase III trial comparing adjuvant chemotherapy with S-1 vs. surgery alone in patients with resectable biliary tract cancer (JCOG1202: ASCOT).
    Ikeda, Masafumi
    Nakachi, Kohei
    Konishi, Masaru
    Mitsunaga, Shuichi
    Mizusawa, Junki
    Uesaka, Katsuhiko
    Saiura, Akio
    Yanagimoto, Hiroaki
    Morinaga, Soichiro
    Eba, Junko
    Katayama, Hiroshi
    Fukuda, Haruhiko
    Ishii, Hiroshi
    Okusaka, Takuji
    Furuse, Junji
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [48] Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial
    Monk, Bradley J.
    Colombo, Nicoletta
    Oza, Amit M.
    Fujiwara, Keiichi
    Birrer, Michael J.
    Randall, Leslie
    Poddubskaya, Elena, V
    Scambia, Giovanni
    Shparyk, Yaroslav, V
    Lim, Myong Cheol
    Bhoola, Snehalkumar M.
    Sohn, Joohyuk
    Yonemori, Kan
    Stewart, Ross A.
    Zhang, Xiaoxi
    Smith, Julia Perkins
    Linn, Carlos
    Ledermann, Jonathan A.
    LANCET ONCOLOGY, 2021, 22 (09): : 1275 - 1289
  • [49] Phase III randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with AJCC/UICC (1997) stage 3 and 4 nasopharyngeal cancer of the endemic variety.
    Wee, J
    Tan, EH
    Tai, BC
    Wong, HB
    Leong, SS
    Tan, T
    Chua, ET
    Lee, KM
    Yang, E
    Machin, D
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 488S - 488S
  • [50] A randomized phase II trial of adjuvant chemotherapy with S-1 versus S-1 and gemcitabine (GS) versus gemcitabine alone (GEM) in patients with resected pancreatic cancer (CAP-002 study).
    Yoshitomi, Hideyuki
    Shimizu, Hiroaki
    Yoshidome, Hiroyuki
    Ohtsuka, Masayuki
    Kato, Atsushi
    Furukawa, Katsunori
    Takayashiki, Tsukasa
    Kuboki, Satoshi
    Okamura, Daiki
    Suzuki, Daisuke
    Nakajima, Masayuki
    Aida, Toshiaki
    Miyazaki, Masaru
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345